Picture of RTW Biotech Opportunities logo

RTW — RTW Biotech Opportunities News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeMid CapNeutral

RTW Biotech Opp. - Holding(s) in Company

RNS Number : 1273D

RTW Biotech Opportunities Ltd

06 May 2026

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GG00BKTRRM22

Issuer Name

RTW BIOTECH OPPORTUNITIES LTD

UK or Non-UK Issuer

Non-UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Bluestem Asset Management, LLC

City of registered office (if applicable)

Charlottesville

Country of registered office (if applicable)

United States

4. Details of the shareholder

NameCity of registered officeCountry of registered office
Bluestem Partners, LPWilmington DelawareUSA
5. Date on which the threshold was crossed or reached 05-May-2026 6. Date on which Issuer notified 05-May-2026 7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A)% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)Total of both in % (8.A + 8.B)Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached9.9600000.0000009.96000032250831
Position of previous notification (if applicable)10.1400000.00000010.140000
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached 8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible)Number of direct voting rights (DTR5.1)Number of indirect voting rights (DTR5.2.1)% of direct voting rights (DTR5.1)% of indirect voting rights (DTR5.2.1)
GG00BKTRRM22322508319.960000
Sub Total 8.A322508319.960000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrumentExpiration dateExercise/conversion periodNumber of voting rights that may be acquired if the instrument is exercised/converted% of voting rights
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrumentExpiration dateExercise/conversion periodPhysical or cash settlementNumber of voting rights% of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification obligation 2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling personName of controlled undertaking% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Michael D. BillsBluestem Asset Management LLC9.9600000.0000009.960000%
10. In case of proxy voting Name of the proxy holder   The number and % of voting rights held   The date until which the voting rights will be held   11. Additional Information Michael D. Bills has sole authority for Bluestem Asset Management, LLC, as its Managing Member. Bluestem Asset Management, LLC is the General Partner of the Shareholder, Bluestem Partners, LP, and is authorized to act for Bluestem Partners, LP on all matters.   The last notification was submitted to the FCA and the issuer on May 24, 2024. Bluestem's interest in RTW at that time was 10.14%. 12. Date of Completion 05-May-2026 13. Place Of Completion Charlottesville, VA USA This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     HOLFZGGKNKLGVZM

Recent news on RTW Biotech Opportunities

See all news